annual CAPEX:
$3.91M+$2.49M(+175.85%)Summary
- As of today (July 1, 2025), CYTK annual capital expenditures is $3.91 million, with the most recent change of +$2.49 million (+175.85%) on December 31, 2024.
- During the last 3 years, CYTK annual CAPEX has fallen by -$44.97 million (-92.01%).
- CYTK annual CAPEX is now -92.01% below its all-time high of $48.87 million, reached on December 31, 2021.
Performance
CYTK CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$5.66M+$4.37M(+339.07%)Summary
- As of today (July 1, 2025), CYTK quarterly capital expenditures is $5.66 million, with the most recent change of +$4.37 million (+339.07%) on March 1, 2025.
- CYTK quarterly CAPEX is now -68.10% below its all-time high of $17.75 million, reached on December 31, 2021.
Performance
CYTK quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$9.57M+$5.66M(+145.01%)Summary
- As of today (July 1, 2025), CYTK TTM capital expenditures is $9.57 million, with the most recent change of +$5.66 million (+145.01%) on March 1, 2025.
- CYTK TTM CAPEX is now -80.42% below its all-time high of $48.87 million, reached on December 31, 2021.
Performance
CYTK TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CYTK CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +175.8% | - | - |
| 3 y3 years | -92.0% | +501.3% | -77.8% |
| 5 y5 years | +49.1% | +444.1% | +126.9% |
CYTK CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.0% | +175.8% | -10.5% | +7255.8% | -72.8% | +575.9% |
| 5 y | 5-year | -92.0% | +175.8% | -68.1% | +7255.8% | -80.4% | +575.9% |
| alltime | all time | -92.0% | +3024.8% | -68.1% | >+9999.0% | -80.4% | >+9999.0% |
CYTK CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $5.66M(+339.1%) | $9.57M(+145.0%) |
| Dec 2024 | $3.91M(+175.8%) | $1.29M(+84.0%) | $3.91M(+45.0%) |
| Sep 2024 | - | $701.00K(-63.4%) | $2.69M(+21.7%) |
| Jun 2024 | - | $1.92M(+2387.0%) | $2.21M(+56.2%) |
| Dec 2023 | $1.42M(-87.5%) | $77.00K(-65.0%) | $1.42M(-68.8%) |
| Sep 2023 | - | $220.00K(-69.3%) | $4.54M(-57.4%) |
| Jun 2023 | - | $717.00K(+78.4%) | $10.65M(-1.3%) |
| Mar 2023 | - | $402.00K(-87.5%) | $10.79M(-4.8%) |
| Dec 2022 | $11.34M(-76.8%) | $3.21M(-49.4%) | $11.34M(-56.2%) |
| Sep 2022 | - | $6.33M(+638.7%) | $25.88M(-26.6%) |
| Jun 2022 | - | $857.00K(-9.0%) | $35.25M(-18.4%) |
| Mar 2022 | - | $942.00K(-94.7%) | $43.19M(-11.6%) |
| Dec 2021 | $48.87M(+342.2%) | $17.75M(+13.1%) | $48.87M(+29.7%) |
| Sep 2021 | - | $15.70M(+78.6%) | $37.67M(+53.4%) |
| Jun 2021 | - | $8.79M(+32.7%) | $24.57M(+47.7%) |
| Mar 2021 | - | $6.63M(+1.1%) | $16.64M(+50.5%) |
| Dec 2020 | $11.05M(+322.0%) | $6.55M(+152.9%) | $11.05M(+90.5%) |
| Sep 2020 | - | $2.59M(+200.0%) | $5.80M(+37.6%) |
| Jun 2020 | - | $864.00K(-17.0%) | $4.22M(+23.9%) |
| Mar 2020 | - | $1.04M(-20.3%) | $3.40M(+29.9%) |
| Dec 2019 | $2.62M(+194.6%) | $1.31M(+29.8%) | $2.62M(+72.0%) |
| Sep 2019 | - | $1.01M(+1912.0%) | $1.52M(+74.1%) |
| Jun 2019 | - | $50.00K(-80.5%) | $875.00K(-1.1%) |
| Mar 2019 | - | $257.00K(+22.4%) | $885.00K(-0.4%) |
| Dec 2018 | $889.00K(-69.1%) | $210.00K(-41.3%) | $889.00K(-39.1%) |
| Sep 2018 | - | $358.00K(+496.7%) | $1.46M(-6.0%) |
| Jun 2018 | - | $60.00K(-77.0%) | $1.55M(-11.3%) |
| Mar 2018 | - | $261.00K(-66.5%) | $1.75M(-39.2%) |
| Dec 2017 | $2.88M(+80.3%) | $780.00K(+72.9%) | $2.88M(-2.5%) |
| Sep 2017 | - | $451.00K(+74.8%) | $2.95M(+5.2%) |
| Jun 2017 | - | $258.00K(-81.4%) | $2.81M(+9.4%) |
| Mar 2017 | - | $1.39M(+62.5%) | $2.56M(+60.7%) |
| Dec 2016 | $1.60M(+184.0%) | $854.00K(+179.1%) | $1.60M(+68.7%) |
| Sep 2016 | - | $306.00K(+1812.5%) | $946.00K(+36.5%) |
| Jun 2016 | - | $16.00K(-96.2%) | $693.00K(-18.7%) |
| Mar 2016 | - | $420.00K(+105.9%) | $852.00K(+51.6%) |
| Dec 2015 | $562.00K(-49.1%) | $204.00K(+284.9%) | $562.00K(-7.1%) |
| Sep 2015 | - | $53.00K(-69.7%) | $605.00K(-7.2%) |
| Jun 2015 | - | $175.00K(+34.6%) | $652.00K(-27.6%) |
| Mar 2015 | - | $130.00K(-47.4%) | $901.00K(-18.4%) |
| Dec 2014 | $1.10M | $247.00K(+147.0%) | $1.10M(-0.5%) |
| Sep 2014 | - | $100.00K(-76.4%) | $1.11M(+2.9%) |
| Jun 2014 | - | $424.00K(+27.3%) | $1.08M(+54.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $333.00K(+32.1%) | $698.00K(+28.8%) |
| Dec 2013 | $542.00K(+333.6%) | $252.00K(+265.2%) | $542.00K(+55.3%) |
| Sep 2013 | - | $69.00K(+56.8%) | $349.00K(+7.1%) |
| Jun 2013 | - | $44.00K(-75.1%) | $326.00K(+12.8%) |
| Mar 2013 | - | $177.00K(+200.0%) | $289.00K(+131.2%) |
| Dec 2012 | $125.00K(-71.8%) | $59.00K(+28.3%) | $125.00K(+37.4%) |
| Sep 2012 | - | $46.00K(+557.1%) | $91.00K(-37.7%) |
| Jun 2012 | - | $7000.00(-46.2%) | $146.00K(-48.0%) |
| Mar 2012 | - | $13.00K(-48.0%) | $281.00K(-36.6%) |
| Dec 2011 | $443.00K(-10.1%) | $25.00K(-75.2%) | $443.00K(-12.3%) |
| Sep 2011 | - | $101.00K(-28.9%) | $505.00K(-5.8%) |
| Jun 2011 | - | $142.00K(-18.9%) | $536.00K(+4.3%) |
| Mar 2011 | - | $175.00K(+101.1%) | $514.00K(+4.3%) |
| Dec 2010 | $493.00K(-10.4%) | $87.00K(-34.1%) | $493.00K(-20.1%) |
| Sep 2010 | - | $132.00K(+10.0%) | $617.00K(+11.2%) |
| Jun 2010 | - | $120.00K(-22.1%) | $555.00K(+14.4%) |
| Mar 2010 | - | $154.00K(-27.0%) | $485.00K(-11.8%) |
| Dec 2009 | $550.00K(-16.4%) | $211.00K(+201.4%) | $550.00K(+53.2%) |
| Sep 2009 | - | $70.00K(+40.0%) | $359.00K(-0.3%) |
| Jun 2009 | - | $50.00K(-77.2%) | $360.00K(-27.7%) |
| Mar 2009 | - | $219.00K(+995.0%) | $498.00K(-24.3%) |
| Dec 2008 | $658.00K(-74.3%) | $20.00K(-71.8%) | $658.00K(-36.4%) |
| Sep 2008 | - | $71.00K(-62.2%) | $1.03M(-12.6%) |
| Jun 2008 | - | $188.00K(-50.4%) | $1.18M(-8.1%) |
| Mar 2008 | - | $379.00K(-4.3%) | $1.29M(-49.8%) |
| Dec 2007 | $2.56M(-52.3%) | $396.00K(+80.0%) | $2.56M(-32.6%) |
| Sep 2007 | - | $220.00K(-24.7%) | $3.80M(-29.8%) |
| Jun 2007 | - | $292.00K(-82.4%) | $5.42M(-11.2%) |
| Mar 2007 | - | $1.66M(+1.2%) | $6.10M(+13.6%) |
| Dec 2006 | $5.37M(+266.6%) | $1.64M(-11.0%) | $5.37M(+36.3%) |
| Sep 2006 | - | $1.84M(+88.8%) | $3.94M(+56.6%) |
| Jun 2006 | - | $973.00K(+5.2%) | $2.52M(+31.2%) |
| Mar 2006 | - | $925.00K(+349.0%) | $1.92M(+30.9%) |
| Dec 2005 | $1.47M(+4.6%) | $206.00K(-50.0%) | $1.47M(-14.4%) |
| Sep 2005 | - | $412.00K(+10.2%) | $1.71M(-10.7%) |
| Jun 2005 | - | $374.00K(-20.9%) | $1.92M(+9.7%) |
| Mar 2005 | - | $473.00K(+4.6%) | $1.75M(+24.6%) |
| Dec 2004 | $1.40M(-54.1%) | $452.00K(-26.6%) | $1.40M(+47.7%) |
| Sep 2004 | - | $616.00K(+202.0%) | $948.00K(+185.5%) |
| Jun 2004 | - | $204.00K(+59.4%) | $332.00K(+159.4%) |
| Mar 2004 | - | $128.00K | $128.00K |
| Dec 2003 | $3.05M(-53.6%) | - | - |
| Dec 2002 | $6.57M | - | - |
FAQ
- What is Cytokinetics Incorporated annual capital expenditures?
- What is the all time high annual CAPEX for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual CAPEX year-on-year change?
- What is Cytokinetics Incorporated quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated TTM capital expenditures?
- What is the all time high TTM CAPEX for Cytokinetics Incorporated?
What is Cytokinetics Incorporated annual capital expenditures?
The current annual CAPEX of CYTK is $3.91M
What is the all time high annual CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual capital expenditures is $48.87M
What is Cytokinetics Incorporated annual CAPEX year-on-year change?
Over the past year, CYTK annual capital expenditures has changed by +$2.49M (+175.85%)
What is Cytokinetics Incorporated quarterly capital expenditures?
The current quarterly CAPEX of CYTK is $5.66M
What is the all time high quarterly CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly capital expenditures is $17.75M
What is Cytokinetics Incorporated TTM capital expenditures?
The current TTM CAPEX of CYTK is $9.57M
What is the all time high TTM CAPEX for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high TTM capital expenditures is $48.87M